SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-22-020442
Filing Date
2022-05-16
Accepted
2022-05-16 17:11:47
Documents
14
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A acor-8ka_20220511.htm   iXBRL 8-K/A 35508
2 PRESS RELEASE acor-ex991_7.htm EX-99.1 304444
3 GRAPHIC gfz30a5xwvon000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-22-020442.txt   493421

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20220511.xsd EX-101.SCH 5581
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20220511_lab.xml EX-101.LAB 19296
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20220511_pre.xml EX-101.PRE 11465
8 EXTRACTED XBRL INSTANCE DOCUMENT acor-8ka_20220511_htm.xml XML 3893
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31938 | Film No.: 22930802
SIC: 2836 Biological Products, (No Diagnostic Substances)